Minoxidil Viatris

Minoxidil, the active ingredient in Minoxidil Viatris, is a potassium channel opener presented as a topical solution for topical use. It treats androgenetic alopecia (pattern hair loss) in men and women by stimulating hair follicle activity. GNH USA supplies Minoxidil Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Minoxidil acts on the scalp to address pattern hair loss and related follicular disorders. - Androgenetic alopecia (men): promotes regrowth of scalp hair and slows further loss. - Androgenetic alopecia (women): stimulates new hair growth and improves hair density. - Female pattern hair loss: helps restore hair thickness and reduces shedding.

Common Side Effects: - Scalp irritation: itching or burning sensation at the application site. - Dryness: flaking or scaling of the scalp skin. - Redness: mild erythema where applied. - Unwanted facial hair growth: incidental hair on adjacent skin. - Temporary shedding: increased hair loss during early treatment. - Contact dermatitis: mild allergic skin reaction.

Serious or Rare Side Effects: - Severe allergic reaction: swelling of face, lips, or tongue. - Chest pain or palpitations: signs of systemic vasodilation. - Rapid heartbeat (tachycardia): may indicate systemic absorption. - Dizziness or fainting: due to blood pressure changes. - Severe scalp inflammation: extensive redness or ulceration. - Unexpected weight gain: fluid retention in rare cases.

Before using Minoxidil Viatris, consider the following safety measures. - Pregnancy: safety not established; avoid use unless advised by a healthcare professional. - Breastfeeding: unknown effects; consult a physician before application. - Scalp condition: do not apply to irritated, infected, or wounded skin. - Age restriction: not recommended for children under 18 years. - Concurrent topical products: using other hair‑care agents may increase irritation risk. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Minoxidil may interact with other medications that affect blood pressure or scalp health. Major Interactions (Avoid): - Oral vasodilators (e.g., hydralazine): may cause excessive hypotension. - Antihypertensive drugs: additive blood‑pressure‑lowering effect. - Additional topical minoxidil products: risk of overdose and systemic exposure. Moderate Interactions (Monitor Closely): - Hair dyes or chemical treatments: may increase scalp irritation. - Alcohol consumption: can enhance systemic absorption. - Antifungal scalp agents: may alter drug absorption dynamics.